BILLION IND (02299) released its interim results, with profit attributable to shareholders of 985 million yuan, an increase of 161.57% year-on-year.

17:11 17/08/2026

Baijun Industrial (02299) announced its results for the six months ended June 30, 2026. During the period, the group achieved revenue of 12.712 billion yuan, an increase of 34% year-on-year; the profit attributable to shareholders was 985 million yuan, an increase of 161.57% year-on-year; the basic earnings per share were 0.47 yuan.

BILLION IND (02299) released its performance for the six months ended June 30, 2026, during which the group achieved revenue of 12.712 billion RMB, a 34% increase year-on-year; profit attributable to equity holders was 985 million RMB, a year-on-year increase of 161.57%; basic earnings per share were 0.47 RMB.

HJ SCIENCE-B (06132) is proposed to be renamed as "Huajian Future (Chengdu) Biotechnology Co., Ltd."

HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

HJ SCIENCE-B (06132) is proposed to be renamed as "Huajian Future (Chengdu) Biotechnology Co., Ltd."

HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.